Explain this page
Arphra AIPlain-English read on Abbott Laboratories’s valuation06-04today
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$142.81
+58.27% vs spot
Recommendation
Strong Buy
18 of 19 methods
Method spread
7bull10bear
±5% threshold
Analyst PT consensus: $127.46 (+41.25%)
Candlestick · 1Y
Open in chart workstation →ABT
88.67-32.97%H 139.06L 81.97MA50 92.39MA200 115.37Avg vol 8.7M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.42% | +0.69% | +6.82% | -18.49% | -28.79% | -27.98% | -31.78% | -15.43% | -19.17% | +141.33% | +54704.13% |
Insider · 30d
History →Bought
$2.22M
4 txns
Sold
$485.32K
6 txns
Net flow
+$1.73M
Aftermarket
LiveLast trade
$90.23
208 sh
Bid
$90.22
200 sh
Ask
$90.41
100 sh
Spread
$0.190
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $11.16B | $1.08B | $0.62 |
| Q4 Dec 2025 | $11.46B | $1.78B | $1.02 |
| Q3 Sep 2025 | $11.37B | $1.64B | $0.94 |
| Q2 Jun 2025 | $11.14B | $1.78B | $1.01 |
| Q1 Mar 2025 | $10.36B | $1.33B | $0.76 |
| Q4 Dec 2024 | $10.97B | $9.23B | $5.27 |
Sector & industry today
LiveSectors
- Utilities+1.33%
- Basic Materials+0.95%
- Industrials+0.69%
- Consumer Cyclical+0.37%
- Technology+0.20%
- Financial Services+0.01%
- Healthcare-0.12%
- Energy-0.32%
- Real Estate-0.36%
- Consumer Defensive-0.48%
- Communication Services-0.73%
Top industries (issuer's industry highlighted)
- Medical - Devices-0.27%
- Business Equipment & Supplies+3.25%
- Gold+2.89%
- Auto - Dealerships-2.67%
- Trucking-2.56%
- Silver+2.53%
- Broadcasting+2.38%
- Copper+2.09%
- Steel-2.03%
- Electrical Equipment & Parts+1.99%
- Auto - Recreational Vehicles+1.99%
- Oil & Gas Refining & Marketing-1.96%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$127.46
+41.25% upside
Low
$92.00
Median
$125.00
High
$152.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- Abbott's CGM Growth Story Stays Intact Despite Q1 Moderationzacks.com·Jun 16, 2026
- The Hormuz Reopening Trade: These 20 Large-Cap Stocks Still Haven't Caught Up To Pre-War Levelsbenzinga.com·Jun 15, 2026
- Abbott (ABT) Stock Declines While Market Improves: Some Information for Investorszacks.com·Jun 12, 2026
- Abbott declares 410th consecutive quarterly dividendgurufocus.com·Jun 12, 2026
- Abbott declares 410th consecutive quarterly dividendprnewswire.com·Jun 12, 2026
- Abbott declares 410th consecutive quarterly dividendprnewswire.com·Jun 12, 2026
- Abbott Laboratories Remains Structurally Undervaluedseekingalpha.com·Jun 12, 2026
- Abbott (ABT) Dips More Than Broader Market: What You Should Knowzacks.com·Jun 10, 2026
Peers
- UNHUnitedHealth Group Incorporated$368.78$334.73B
- NVSNovartis AG$146.57$279.67B
- MRKMerck & Co., Inc.$112.17$277.03B
- NVONovo Nordisk A/S$43.88$195B
- TMOThermo Fisher Scientific Inc.$469.21$174.37B
- GILDGilead Sciences, Inc.$131.65$163.41B
- ISRGIntuitive Surgical, Inc.$457.78$162.13B
- SYKStryker Corporation$294.73$112.88B
Total assets
$86.71B
Total debt
$15.07B
Cash & equiv
$8.52B
Operating CF
$9.57B
Free cash flow
$7.4B
Buybacks
-$893M
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
STARKS DANIEL J director | Buy | 10,000 | $926.54K | Apr 27, 2026 |
Boudreau Philip P officer: EVP AND CFO | Buy | 2,200 | $201.3K | Apr 23, 2026 |
MCCOY JOHN A. JR. officer: VICE PRESIDENT AND CONTROLLER | Sell | 585 | $67.61K | Mar 02, 2026 |
Shroff Eric officer: Senior Vice President | Sell | 709 | $81.95K | Mar 02, 2026 |
Cushman Elizabeth C. officer: EVP, GC AND SECRETARY | Sell | 263 | $30.4K | Mar 02, 2026 |
Salvadori Daniel Gesua Sive officer: EVP AND GROUP PRESIDENT | Sell | 885 | $102.29K | Mar 02, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $44.33B | $8.05B | $6.52B | $3.72 | +14.72% |
| FY 2024 | $41.95B | $6.83B | $13.4B | $7.64 | +31.95% |
| FY 2023 | $40.11B | $6.44B | $5.72B | $3.27 | +14.27% |
| FY 2022 | $43.65B | $8.36B | $6.93B | $3.91 | +15.88% |
| FY 2021 | $43.08B | $9.2B | $7.07B | $3.94 | +16.42% |